http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2235544-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2003-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c884315674d21cf27eefe2a9eb8d1dd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810bef07000a90214811a294aee81e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d385b0451e9f8b5ed3a39d741aa00ef7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acd11e0c0478c8147227b746068ba838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f3cc8abd8e99bffe9aeaea18738a75d
publicationDate 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2235544-C1
titleOfInvention Preparation eliciting analgetic, antripyretic and spasmolytic effect
abstract FIELD: medicine, pharmacy. n SUBSTANCE: invention relates to the development of the combined preparation based on sodium metamizole and tempidon eliciting analgetic, antipyretic and spasmolytic activity. Preparation is made as an envelope-covered tablet. Tablet core comprises active substances sodium metamizole and tempidon and accessory substances - maize starch, microcrystalline cellulose, polyvinylpyrrolidone, sodium starch, glycolate, talk and magnesium stearate. Envelope comprises Opadory Green, titanium dioxide, talk, polyethylene glycol-6000, dye blue, quinoline yellow. The combined preparation shows low toxicity, it doesn't induce disturbances of biochemical and hematological indices of blood owing to qualitative and quantitative ratio of components. n EFFECT: improved and valuable medicinal properties of preparation. n 2 dwg, 8 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-1069-U1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-013802-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-65912-B1
priorityDate 2003-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408264951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449846717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450114205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23290570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23689139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453253805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID143646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450756958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707770

Total number of triples: 41.